Increasing evidence has demonstrated that many p53 mutants contribute to cancer progression by altering activities of other transcription factors, such as p63, p73, Ets2, and Nrf2, as their gain-of-function (GOF) activities [55,56,57]. Here, TP53 is linked to cancer.